Top stories
Marketing & Media947 Joburg Day 2026 transforms into a cultural playground with all-star line-up
Primedia Broadcasting 22 Jun 2026
#CannesLions
Kenya’s The Partnership Agency wins Bronze Lion
Karabo Ledwaba
Silver for Mtana ka Gogo leads SA's latest wins
Karabo Ledwaba
Walk in the footsteps of SA schoolchildren and get them school shoes
Danette Breitenbach
Trending
Subscribe & Follow
Advertise your job vacancies
Experts seek WHO nod for postpartum haemorrhage drug
A drug many health experts say can drastically cut postpartum haemorrhage - the leading cause of maternal deaths in the developing world - will be in the spotlight this month during the World Health Organization's (WHO) biennial review of its model list of essential medicines.
Health groups are urging WHO to include misoprostol for the prevention and management of postpartum haemorrhage (PPH), or excessive bleeding following childbirth. WHO in 2009 denied misoprostol for prevention of PPH but proponents hope new evidence presented for the 21-25 March WHO meeting in the Ghanaian capital Accra will bring a change. Read the article.
